TickerFactsScreenerDevelopers

Monopar Therapeutics (MNPR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$1.19M2017: -$16.60M2018: -$3.33M2019: -$4.32M2020: -$6.51M2021: -$9.13M2022: -$10.54M2023: -$8.83M2024: -$16.16M2025: -$16.70M-$16.70M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$16.70M-3.4%
2024-$16.16M-83.0%
2023-$8.83M+16.2%
2022-$10.54M-15.4%
2021-$9.13M-40.2%
2020-$6.51M-50.5%
2019-$4.32M-29.8%
2018-$3.33M+79.9%
2017-$16.60M-1291.9%
2016-$1.19M—